Quick answer: buying peptides online is legal only in narrow cases, such as filling a prescription for an FDA-approved peptide drug at a state-licensed pharmacy. Most peptides sold on “research chemical” websites are unapproved new drugs, and FDA warning letters from December 2024 through 2026 say a “research use only” or “not for human consumption” label does not make them legal to sell for people.[1][2] In July 2026, a federal judge sentenced the owner of one such online business to 70 months in prison.[3]
This guide explains what the law says, who enforces it, the risks for buyers and sellers, and how to report a problem. It does not name or recommend any seller. For the wider picture, see our hub on FDA and peptide regulation and our overview, are peptides legal?
Why most peptides sold online are unapproved drugs
Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), a product is a “drug” if it is intended to diagnose, treat or prevent disease, or to affect the structure or function of the body (section 201(g)(1)). A “new drug” cannot be sold across state lines unless FDA has approved it (section 505(a)). Selling one anyway is a prohibited act under section 301(d).[1]
FDA decides what a product is “intended” for by looking at all the evidence, not just the label. Its rule on intended use is 21 CFR 201.128.[1] So a vial of BPC-157, TB-500 or retatrutide marketed with dosing charts, before-and-after language or bacteriostatic water for mixing is treated as a drug for people, whatever the fine print says. Our guide to research use only peptides explains where that label really comes from.
What FDA warning letters say about “research use only”
FDA’s warning letters to online peptide sellers follow a clear pattern:
| Date | What FDA cited | FDA’s finding |
|---|---|---|
| Dec 10, 2024 | Semaglutide, retatrutide, cagrilintide, tirzepatide and mazdutide labeled “research use only” | Website content on weight loss and blood sugar showed the products were intended as drugs for people[2] |
| Mar 31, 2026 | Retatrutide, tirzepatide and bacteriostatic water labeled “research use only” and “not intended for human consumption” | Evidence from the website established the products were drugs for human use[1] |
FDA’s GLP-1 safety page says the agency has warned companies selling products “falsely labeled” as being for research, and that some were sold directly to consumers with dosing instructions.[6] A warning letter is not a court ruling. It is FDA’s formal notice that it believes the law is being broken, and it can lead to seizures, injunctions or criminal referral if the firm does not fix the problems. Read more in our guide to FDA warning letters on peptides.
Criminal prosecutions: a 2026 example
The case against an online seller called Paradigm Peptides shows how far enforcement can go. According to the U.S. Attorney’s Office for the Northern District of Indiana:[3][4]
- The business sold peptides, hCG and selective androgen receptor modulators (SARMs) online.
- Investigators found that many products sold as SARMs actually contained testosterone, a controlled substance.
- The owner and a co-defendant pleaded guilty on December 10, 2025. The charges included introducing unapproved new drugs into interstate commerce with intent to defraud or mislead, and the owner also pleaded guilty to illegal importation.
- On July 30, 2026, the owner was sentenced to 70 months in prison and the co-defendant to 16 months, with $78,317.52 in restitution.
- Buyers from April 2019 to March 2024 were told they may be victims.
The case matters for buyers too: people who paid for one product received another, including a controlled substance they did not know they were taking.
Counterfeit GLP-1 drugs
Fake brand-name products are a separate problem from “research” peptides. FDA has warned about counterfeit semaglutide pens in the U.S. supply chain several times:[5]
- December 2023: counterfeit Ozempic 1 mg pens, with counterfeit needles whose sterility could not be confirmed.
- April 2025: several hundred counterfeit 1 mg units seized, lot PAR0362.
- December 2025: counterfeit 1 mg pens labeled with lot PAR1229, which is also a real lot number. FDA explained how to tell them apart by the label layout.
Independent testing shows the risk. In a 2024 study, researchers made test purchases of semaglutide from illegal online pharmacies. None of the three prefilled pens ordered ever arrived. The three vials that did arrive held 29% to 39% more drug than labeled, had a measured purity of only about 8% to 14%, and all contained bacterial endotoxin.[7]
Legal risks for buyers
Federal enforcement has mostly targeted sellers, not individual buyers. Buyers still take on real risks:
- Import problems. FDA says that “in most circumstances” it is illegal for individuals to import drugs for personal use. Its personal importation policy allows limited exceptions, generally up to a 3-month supply for a serious condition.[8] Packages from overseas can be detained or refused. See peptide import laws.
- Becoming a distributor. Reselling, splitting or sharing vials with friends or clients can turn a buyer into someone “introducing” unapproved drugs into commerce.
- Controlled substances. As the Indiana case showed, a product can contain a controlled drug you did not order. See DEA peptide classification.
- Sports. Many peptides are banned for tested athletes. See peptides and the WADA Prohibited List.
- Little recourse. Unapproved products have no FDA-reviewed label, no recall system you can rely on and often no real company address.
Legal risks for sellers
Sellers face the most exposure: warning letters, product seizures, injunctions, criminal charges, prison and forfeiture.[1][3] Advertising also matters. Health claims that are not backed by evidence can draw action from the Federal Trade Commission as well as FDA. Our guide to peptide advertising rules covers this.
How to report a problem
| Problem | Where to report |
|---|---|
| A side effect or bad reaction | FDA MedWatch, online or by fax to 1-800-FDA-0178[6] |
| A website selling drugs illegally | FDA’s online form for reporting unlawful internet sales of medical products |
| A scam, non-delivery or misleading ad | FTC at ReportFraud.ftc.gov[10] |
| A counterfeit brand-name pen | FDA MedWatch and the drug’s manufacturer[5] |
If you have a serious reaction, get medical care first. Your state attorney general’s consumer protection office and your card issuer’s dispute process may also help with fraud or non-delivery.
Consumer protections that do apply
FDA says a safe online pharmacy always requires a prescription, gives a physical address and phone number in the U.S., has a licensed pharmacist on staff to answer questions and is licensed by a state board of pharmacy. FDA also warns against sites with prices that seem too good to be true or that ship damaged, foreign-language or expired packaging.[9] These protections only apply when you buy a prescription drug through a licensed pharmacy. They do not cover “research chemical” sites. For the approved route, see telehealth peptide prescriptions and our profile of tirzepatide.
This is general information, not legal advice. If you are facing a seizure notice, a subpoena or a charge, talk to a lawyer licensed in your state.
